The NRAS mutation is found in several cancers such as melanoma (13 ~ 25%), colorectal cancer (1 ~ 6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is known that the response to colorectal cancer drug such as Erbitux and Cetuximab decreased and the prognosis of the patient with metastatic colorectal cancer is poor if the patient has NRAS mutation.
PNAClamp™ Mutation Detection Kit NRAS
For detection of NRAS mutations in tissue biopsies
Cat. No. PNAC-1101
Other products
PANAMutyper™ R KRAS
To detect KRAS mutations and determine their response to various...
Glycerol (500 mL)
Part number: GB0232 Supplement or stabilizer in cryopreservation.
AccuBand 100 bp DNA Marker II, 500 μl – DM2000
The AccuBand™ 100 bp DNA Marker II kit is a...
PathoSEEK AHP starter kit (200 samples)
The AHP starter kit includes all the reagents a testing...